Schizophrenia in a Primary Care Setting

Current Psychiatry Reports
Rose JonesChristopher Fear

Abstract

In recent years, the focus of mental health care for people with schizophrenia has shifted from an expectation of lifelong disability to a 'recovery' approach in which patients and specialists anticipate discharge to management within primary care. Although the active symptoms of mental illness are generally well-managed with modern pharmacotherapy, primary care physicians often express concern about their lack of understanding and expertise in general management of schizophrenia. Moreover, the ability of patients to access care for their physical disorders in a timely fashion together with a higher prevalence of physical co-morbidities is likely to be responsible for the greater mortality and premature death of this already stigmatised and disadvantaged group. This paper focuses on new evidence over the past 5 years, considering the management of physical and mental health of schizophrenia patients in primary care, optimal processes and the reasons why these may not always be realised in practice.

References

Jan 1, 1989·Schizophrenia Bulletin·P Allebeck
Jan 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M BirchwoodH Jackson
Nov 7, 1998·The Australian and New Zealand Journal of Psychiatry·A Barbato
Mar 17, 2004·Social Psychiatry and Psychiatric Epidemiology·Vaughan J CarrJenny L Chapman
Jun 19, 2004·BMJ : British Medical Journal·David Shiers, Helen Lester
Feb 5, 2005·Epidemiologia e psichiatria sociale·Maxine X Patel
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Richard Warner
Aug 2, 2005·The British Journal of Psychiatry. Supplement·UNKNOWN International Early Psychosis Association Writing Group
Aug 4, 2006·Psychiatry and Clinical Neurosciences·Alp UçokSahap Erkoç
Apr 4, 2007·Schizophrenia Bulletin·Alison R YungPatrick McGorry
Sep 14, 2007·Social Science & Medicine·Dag Album, Steinar Westin
Nov 21, 2007·The British Journal of Psychiatry. Supplement·Swaran P Singh
Dec 18, 2008·Schizophrenia Research·Andor E SimonDaniel Umbricht
Sep 25, 2009·Psychological Medicine·P McGorryA Yung
Feb 3, 2010·Psychological Medicine·P BosanacD J Castle
Nov 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Victoria BirdElizabeth Kuipers
Oct 6, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Brynmor Lloyd-EvansSonia Johnson
Feb 22, 2012·The American Journal of Medicine·Mark VironOliver Freudenreich
Mar 7, 2012·Archives of General Psychiatry·Paolo Fusar-PoliPhilip McGuire
Jul 28, 2012·Archives of Psychiatric Nursing·Patricia Galon, Christine Heifner Graor
Nov 13, 2012·Schizophrenia Bulletin·Alison R YungThomas H McGlashan
Apr 4, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Richard Warner
May 25, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Max BirchwoodSwaran P Singh
Jul 17, 2013·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Tai Pong LamYin Shuen Ku
Dec 19, 2013·PloS One·Sarah HardoonDavid P J Osborn
Mar 4, 2014·Acta Psychiatrica Scandinavica·K K AndersonK McKenzie
Apr 30, 2014·Psychiatry Research·Patrick W CorriganGreer Sullivan
Oct 15, 2014·Psychiatric Rehabilitation Journal·Dinesh MittalGreer Sullivan
Oct 18, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Mike J CrawfordDavid Shiers
Nov 16, 2014·BMJ : British Medical Journal·Chris Millard, Simon Wessely
Dec 20, 2014·BMJ Open·Louise MarstonDavid P J Osborn

❮ Previous
Next ❯

Citations

May 13, 2017·International Journal of Psychiatry in Clinical Practice·Alkomiet HasanUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Nov 30, 2018·BMC Family Practice·M C CastillejosB Moreno-Küstner
Oct 31, 2017·Journal of Technology in Behavioral Science·Marek KrzystanekKatarzyna Skałacka
Apr 9, 2020·International Journal of Environmental Research and Public Health·Kuan-Yi TsaiYu-Mei Chou
Mar 30, 2017·Frontiers in Psychiatry·Rita Riedmüller, Sabine Müller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.